Client Overview
A European multinational pharmaceutical company with a large portfolio of antibiotic products operated across the United States and Most of the World (MoW) markets. The organization managed multiple labeling activities for ANDA products and required consistent Regulatory compliance, submission accuracy, and accelerated turnaround timelines across regions.
To support their expanding Regulatory requirements and maintain compliance standards, the company partnered with Freyr Solutions for comprehensive end-to-end labeling support services.
Background
The client was managing a high volume of ANDA labeling activities across multiple antibiotic products intended for the US and global markets. Maintaining Regulatory consistency while handling evolving Health Authority requirements created operational challenges for internal teams.
The company required a structured labeling support model that could ensure:
- Consistent Regulatory compliance across regions
- Accurate preparation of submission-ready documents
- Faster review and approval cycles
- Reduced operational burden on internal Regulatory teams
Freyr’s expertise in Regulatory labeling and submission support enabled the client to streamline these processes while maintaining high-quality standards.
Services in Scope
End-to-end ANDA labeling support
Preparation and review of labeling components
Creation of submission-ready Regulatory documents
Quality review and compliance checks
Labeling support for US and MoW markets
Alignment with Health Authority requirements
Lifecycle labeling management support
Submission readiness and documentation support
Challenges
The client faced several operational and Regulatory challenges while managing labeling activities across a broad antibiotic portfolio:
• High-volume labeling activities created significant workload pressure on internal teams
• Maintaining consistency across multiple labeling components and regional submissions was difficult
• Frequent Regulatory updates require continuous review and revision of documents
• Manual review processes increased the risk of inconsistencies and submission delays
• Submission timelines were impacted by repeated document revisions and formatting challenges
• The client required a scalable support model capable of handling simultaneous labeling projects without compromising quality
These challenges affected operational efficiency and increased the risk of Health Authorities issuing submission-related observations.
Solution
1
Dedicated End-to-End Labeling Support
Freyr established a comprehensive labeling support framework to manage the client’s ANDA labeling activities from document preparation through final quality review and submission readiness.
2
Structured Review and Compliance Process
A standardized review workflow was implemented to ensure consistency, traceability, and Regulatory compliance across all labeling documents and regional submissions.
3
Submission-Ready Documentation Approach
Freyr’s experts created and reviewed labeling components with a right-first-time approach, reducing the need for repeated revisions and minimizing submission risks.
4
Scalable Operational Delivery Model
The delivery model enabled multiple labeling projects to be managed simultaneously while maintaining quality, turnaround timelines, and Regulatory accuracy across the client’s portfolio.
Impact
Freyr’s structured Regulatory labeling support significantly improved the client’s submission efficiency and compliance outcomes.
Achieved 100% right-first-time submissions across labeling activities
Eliminated “Refuse to File” instances through accurate and compliant documentation
• Improved submission readiness and operational efficiency
Reduced internal workload associated with labeling review and formatting activities
• Streamlined Regulatory workflows across US and MoW markets
Enhanced consistency and quality across labeling documentation
Enabled faster turnaround timelines for submission preparation and review cycles
The engagement helped the client strengthen Regulatory compliance while building a scalable and efficient labeling operations model for its global antibiotic portfolio.
